On Friday, AFLAC Incorporated (NYSE:AFL)’s shares declined -0.48% to $61.81.
With the implementation of the Affordable Care Act, more Americans now have access to major medical insurance. However, results from the 2015 Aflac WorkForces Report released recently by Aflac (AFL), the leading provider of voluntary insurance at the work site in the United States, reveal wide disparities between higher- and lower-income households in terms of financial preparedness, knowledge about health insurance and benefits enrollment. For example, 55 percent of employees in lower-income households (less than $50,000 in household income per year) are not prepared to pay for costs associated with an unanticipated serious illness or accident not covered by major medical insurance, contrast with only 20 percent of employees in higher-income households (more than $100,000 in household income per year). This lack of readiness may present economic and health risks for households already walking a financial tightrope without a safety net to cope with raised medical costs.
The online study, conducted by Research Now on behalf of Aflac between January and February 2015, surveyed 1,977 employers and 5,337 employees at small, medium and large U.S. companies, shedding light on how employees at different ends of the household income spectrum are responding to the continued high cost of health care and the shift to greater consumer control over, and responsibility for, medical expenses.
Aflac Incorporated, through its partner, American Family Life Assurance Company of Columbus, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers various voluntary supplemental insurance products, counting cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan.
Scorpio Tankers Inc. (NYSE:STNG)’s shares gained 2.11% to $9.69.
Scorpio Tankers Inc. (STNG) declared a new $250 million Securities Buyback Program, (ii) that it has recently taken delivery of an MR product tanker and (iii) that it will not exercise the options to purchase two LR2s presently under construction (with deliveries predictable in the fourth quarter of 2016 and first quarter of 2017) from Scorpio Bulkers Inc., a related party.
The Company may repurchase its common stock and bonds in the open market and in privately negotiated transactions, at times and prices that are considered to be appropriate by the Company (in its sole discretion), but is not obligated under the terms of the program to repurchase any of its common stock or bonds.
Scorpio Tankers Inc., together with its auxiliaries, engages in the seaborne transportation of refined petroleum products and crude oil worldwide. As of March 31, 2015, it owned 67 tankers comprising 11 LR2 tanker, 2 LR1 tankers, 15 Handymax tankers, 39 MR tankers with an average age of 1.1 years; and time charters-in 20 product tankers, counting 5 LR2, 5 LR1, 3 MR, and 7 Handymax tankers. The company was founded in 2009 and is based in Monaco, Monaco.
At the end of Friday’s trade, JDS Uniphase Corp (NASDAQ:JDSU)‘s shares surged 1.20% to $13.10.
JDS Uniphase Corp (JDSU) declared that it will take part in several TM Forum Catalyst Projects and technology panels during TM Forum Live! 2015, showcasing its proven expertise enabling and optimizing next generation networks and services. JDSU will cover NFV (network functions virtualization), multi-screen video services, and big data analytics, addressing these major trends driving advanced communications. TM Forum Live! 2015 takes place June 1-4 at the Acropolis in Nice, France.
JDSU actively collaborates with global service providers and ecosystem partners, as evidenced in current TM Forum projects, to demonstrate the power of value-added visibility in transforming the quality and profitability of future networks and services. JDSU delivers real-time intelligence across the end-to-end service path and actionable insight to differentiate quality of experience, improve efficiency, and diversify revenue. These benefits are driving new investment in JDSU solutions, as declared recently with Partner Communications and SoftBank Mobile.
JDS Uniphase Corporation provides network and service enablement solutions and optical products worldwide. The company’s Network and Service Enablement segment offers network and service enablement solutions that enable the design, development, deployment, and maintenance of communication equipment and networks.
Agilent Technologies Inc (NYSE:A), ended its Friday’s trading session with -0.60% loss, and closed at $40.29.
Agilent Technologies Inc (A) declared new additions to its market-leading SureSelect target-enrichment product family, which has already enabled researchers to identify more than 50 Mendelian disease-causing genes.
The new products—the SureSelect Human All Exon V6, V6+UTR and V6+COSMIC—are designed to address the current limitations of exome sequencing, giving researchers better coverage of hard-to-capture regions and providing deep coverage of relevant regions, with minimal sequencing.
Thaysen noted that the new products cover more regions (counting formerly recognized gaps), enhance the sensitivity of variant calling, and minimize false negative calls.
SureSelect Human All Exon V6+UTR adds untranslated regions of the exome for translational research, while V6+COSMIC adds data from the cancer research database known as the Catalogue Of Somatic Mutations In Cancer.
Agilent Technologies, Inc. provides bio-analytical solutions and services to the life sciences, diagnostics and genomics, chemical analysis, communications, and electronics industries worldwide. The companys Life Sciences and Diagnostics segment offers liquid chromatography systems, columns, and components; liquid chromatography mass spectrometry systems; laboratory software and informatics systems; laboratory automation and robotic systems; dissolution testing; nucleic acid solutions; nuclear magnetic resonance, magnetic resonance imaging, and X-ray diffraction systems; immunohistochemistry; in situ hybridization; hematoxylin and eosin staining; special staining, DNA mutation detection; genotyping; gene copy number determination; identification of gene rearrangements; DNA methylation and gene expression profiling; next generation sequencing target enrichment; and automated gel electrophoresis-based sample analysis systems.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
